REGN
Price
$691.86
Change
+$6.98 (+1.02%)
Updated
Mar 4, 11:30 AM (EDT)
Capitalization
76.39B
58 days until earnings call
STRO
Price
$1.41
Change
-$0.02 (-1.40%)
Updated
Mar 4, 11:34 AM (EDT)
Capitalization
117.92M
22 days until earnings call
Ad is loading...

REGN vs STRO

Header iconREGN vs STRO Comparison
Open Charts REGN vs STROBanner chart's image
Regeneron Pharmaceuticals
Price$691.86
Change+$6.98 (+1.02%)
Volume$1.36K
Capitalization76.39B
Sutro Biopharma
Price$1.41
Change-$0.02 (-1.40%)
Volume$100
Capitalization117.92M
REGN vs STRO Comparison Chart
Loading...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REGN vs. STRO commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Buy and STRO is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (REGN: $684.87 vs. STRO: $1.43)
Brand notoriety: REGN: Notable vs. STRO: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REGN: 81% vs. STRO: 157%
Market capitalization -- REGN: $76.39B vs. STRO: $117.92M
REGN [@Biotechnology] is valued at $76.39B. STRO’s [@Biotechnology] market capitalization is $117.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 1 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • REGN’s FA Score: 1 green, 4 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than STRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 4 bullish TA indicator(s).

  • REGN’s TA Score: 4 bullish, 5 bearish.
  • STRO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, STRO is a better buy in the short-term than REGN.

Price Growth

REGN (@Biotechnology) experienced а -3.98% price change this week, while STRO (@Biotechnology) price change was -16.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -11.04%, and the average quarterly price growth was -7.19%.

Reported Earning Dates

REGN is expected to report earnings on May 01, 2025.

STRO is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($76.4B) has a higher market cap than STRO($118M). REGN YTD gains are higher at: -3.731 vs. STRO (-22.283). REGN has higher annual earnings (EBITDA): 5.32B vs. STRO (-69.95M). STRO has less debt than REGN: STRO (24.9M) vs REGN (2.7B). REGN has higher revenues than STRO: REGN (14.2B) vs STRO (161M).
REGNSTROREGN / STRO
Capitalization76.4B118M64,746%
EBITDA5.32B-69.95M-7,603%
Gain YTD-3.731-22.28317%
P/E Ratio17.86N/A-
Revenue14.2B161M8,820%
Total CashN/A388M-
Total Debt2.7B24.9M10,859%
FUNDAMENTALS RATINGS
REGN vs STRO: Fundamental Ratings
REGN
STRO
OUTLOOK RATING
1..100
765
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
24
Undervalued
PROFIT vs RISK RATING
1..100
50100
SMR RATING
1..100
5296
PRICE GROWTH RATING
1..100
6393
P/E GROWTH RATING
1..100
89100
SEASONALITY SCORE
1..100
13n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REGN's Valuation (4) in the Biotechnology industry is in the same range as STRO (24) in the Pharmaceuticals Major industry. This means that REGN’s stock grew similarly to STRO’s over the last 12 months.

REGN's Profit vs Risk Rating (50) in the Biotechnology industry is somewhat better than the same rating for STRO (100) in the Pharmaceuticals Major industry. This means that REGN’s stock grew somewhat faster than STRO’s over the last 12 months.

REGN's SMR Rating (52) in the Biotechnology industry is somewhat better than the same rating for STRO (96) in the Pharmaceuticals Major industry. This means that REGN’s stock grew somewhat faster than STRO’s over the last 12 months.

REGN's Price Growth Rating (63) in the Biotechnology industry is in the same range as STRO (93) in the Pharmaceuticals Major industry. This means that REGN’s stock grew similarly to STRO’s over the last 12 months.

REGN's P/E Growth Rating (89) in the Biotechnology industry is in the same range as STRO (100) in the Pharmaceuticals Major industry. This means that REGN’s stock grew similarly to STRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
REGNSTRO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 8 days ago
61%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NECB23.410.15
+0.64%
NorthEast Community Bancorp
MTB188.81-1.56
-0.82%
M&T Bank Corp
RPAY7.12-0.09
-1.25%
Repay Holdings Corp
OMAB75.07-2.16
-2.80%
Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS
BCAB0.31-0.02
-5.59%
BioAtla

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with IDYA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-1.99%
IDYA - REGN
39%
Loosely correlated
-7.10%
TECH - REGN
39%
Loosely correlated
-0.91%
CRNX - REGN
37%
Loosely correlated
-4.47%
INCY - REGN
36%
Loosely correlated
-4.29%
STRO - REGN
36%
Loosely correlated
-10.06%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with NUVB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then NUVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-10.06%
NUVB - STRO
52%
Loosely correlated
-7.61%
STOK - STRO
51%
Loosely correlated
-5.73%
TRDA - STRO
47%
Loosely correlated
-5.11%
KRYS - STRO
45%
Loosely correlated
-4.01%
ALGS - STRO
44%
Loosely correlated
-14.23%
More